Clinical Study
Efficacy and Outcomes of Intrathecal Analgesia as Part of an Enhanced Recovery Pathway in Colon and Rectal Surgical Patients
| | Age at operation, median (IQR) | 52 (37–65) | | Patient sex, (%) | | | Male | 308 (51) | | Female | 293 (49) | | Surgical approach, (%) | | | Open | 356 (59%) | | Minimally invasive | 245 (41%) | | Length of stay (days), median (IQR) | 3 (2–5) | | Intrathecal medications administered, (%) | | | Opioid only | 547 (91%) | | Opioid + local anesthetic | 54 (9%) | | Ileus, (%) | 95 (16%) | | Postoperative pain scores, median (IQR) | | | 4 hours | 3 (1–5) | | 8 hours | 2 (1–4) | | 16 hours | 3 (1–5) | | 24 hours | 4 (2–5) | | 48 hours | 3 (2–5) | | 48-hour maximum pain score, median (IQR) | 6 (4–7) | | Total OME, median (IQR) | 24 (0–83) | | Number of patients receiving no OME, (%) | 170 (28%) |
|
|
OME: oral morphine equivalent; IQR: interquartile range.
|
